Amalgamated Bank’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-63,389
Closed -$11.6M 2200
2021
Q2
$11.6M Buy
63,389
+51,432
+430% +$9.45M 0.09% 174
2021
Q1
$1.83M Sell
11,957
-431
-3% -$65.9K 0.07% 268
2020
Q4
$1.94M Sell
12,388
-30
-0.2% -$4.69K 0.07% 248
2020
Q3
$1.42M Sell
12,418
-305
-2% -$34.9K 0.06% 315
2020
Q2
$1.43M Sell
12,723
-21,622
-63% -$2.43M 0.07% 273
2020
Q1
$3.08M Sell
34,345
-1,186
-3% -$106K 0.08% 229
2019
Q4
$3.84M Buy
35,531
+1,061
+3% +$115K 0.07% 245
2019
Q3
$3.38M Buy
34,470
+5,188
+18% +$508K 0.07% 247
2019
Q2
$3.84M Sell
29,282
-2,134
-7% -$279K 0.09% 202
2019
Q1
$4.25M Buy
31,416
+677
+2% +$91.5K 0.1% 185
2018
Q4
$2.99M Sell
30,739
-810
-3% -$78.9K 0.08% 206
2018
Q3
$4.39M Sell
31,549
-984
-3% -$137K 0.11% 182
2018
Q2
$4.04M Buy
32,533
+1,852
+6% +$230K 0.1% 191
2018
Q1
$3.42M Buy
30,681
+2,082
+7% +$232K 0.09% 204
2017
Q4
$3.42M Buy
28,599
+2,513
+10% +$301K 0.09% 201
2017
Q3
$3.66M Buy
26,086
+518
+2% +$72.7K 0.11% 174
2017
Q2
$3.11M Buy
25,568
+9,006
+54% +$1.1M 0.1% 185
2017
Q1
$2.01M Sell
16,562
-7,080
-30% -$858K 0.1% 185
2016
Q4
$2.89M Buy
23,642
+4,098
+21% +$501K 0.13% 147
2016
Q3
$2.4M Buy
19,544
+26
+0.1% +$3.19K 0.14% 128
2016
Q2
$2.61M Buy
19,518
+10,881
+126% +$1.45M 0.15% 118
2016
Q1
$1.2M Buy
8,637
+2,042
+31% +$284K 0.12% 152
2015
Q4
$1.26M Sell
6,595
-1,666
-20% -$318K 0.16% 105
2015
Q3
$1.29M Buy
8,261
+320
+4% +$50K 0.14% 126
2015
Q2
$1.44M Buy
7,941
+1,006
+15% +$182K 0.14% 119
2015
Q1
$1.2M Buy
6,935
+1,626
+31% +$282K 0.15% 141
2014
Q4
$982K Sell
5,309
-773
-13% -$143K 0.15% 133
2014
Q3
$1.01M Buy
6,082
+375
+7% +$62.2K 0.15% 134
2014
Q2
$892K Buy
5,707
+718
+14% +$112K 0.13% 155
2014
Q1
$759K Sell
4,989
-95
-2% -$14.5K 0.13% 168
2013
Q4
$676K Buy
+5,084
New +$676K 0.11% 201